Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antivirals/HIV”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04340388
What this trial is testing

Contribution of Dolutegravir to Obesity and Cardiovascular Disease

Who this might be right for
HIV-1-infectionAntiviral Drug Adverse ReactionVascular Diseases+5 more
Augusta University 10
Testing effectiveness (Phase 2)Study completedNCT06039579
What this trial is testing

Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

Who this might be right for
HIV Infections
ViiV Healthcare 44
Not applicableStudy completedNCT00002222
What this trial is testing

Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche 200
Early research (Phase 1)Study completedNCT00002338
What this trial is testing

The Safety and Effectiveness of 935U83 in HIV-Infected Patients

Who this might be right for
HIV Infections
Glaxo Wellcome 40
Post-approval studies (Phase 4)UnknownNCT04225325
What this trial is testing

Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI).

Who this might be right for
HIV-1-infection
ADRIANO LAZZARIN, MD 112
Large-scale testing (Phase 3)Study completedNCT00293267
What this trial is testing

Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 352
Early research (Phase 1)Study completedNCT00001002
What this trial is testing

Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Not applicableStudy completedNCT00002021
What this trial is testing

An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies

Who this might be right for
Herpes SimplexHIV Infections
Astra USA
Large-scale testing (Phase 3)Study completedNCT01721109
What this trial is testing

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 50
Not applicableStudy completedNCT00001116
What this trial is testing

Evaluate the Ability of TNFR:Fc to Decrease the Amount of IL-6 (Interleukin-6) and TNF-alpha (Tumor Necrosis Factor) in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Testing effectiveness (Phase 2)Study completedNCT06214052
What this trial is testing

VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1

Who this might be right for
HIV Infections
ViiV Healthcare 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06338826
What this trial is testing

Study Evaluating the Safety, in Terms of HBV Virological Control At 96 Weeks, of 2 Antiviral Treatment Relief Strategies, in Patients Co-infected with the HIV-1 and HBV Viruses

Who this might be right for
HIV InfectionsHBV Coinfection
ANRS, Emerging Infectious Diseases 140
Testing effectiveness (Phase 2)UnknownNCT01213186
What this trial is testing

Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected Patients

Who this might be right for
Human Immunodeficiency VirusDisorder of Immune Reconstitution
Fu-Sheng Wang 72
Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Testing effectiveness (Phase 2)Study completedNCT00964327
What this trial is testing

TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 42
Not applicableEnded earlyNCT00001069
What this trial is testing

Two Methods of Determining When to Begin or Change Anti-HIV Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,100
Large-scale testing (Phase 3)UnknownNCT00009061
What this trial is testing

Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 624
Testing effectiveness (Phase 2)Study completedNCT00000825
What this trial is testing

The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Study completedNCT03208231
What this trial is testing

Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 61
Early research (Phase 1)Study completedNCT00002128
What this trial is testing

Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients

Who this might be right for
HIV Infections
Gilead Sciences 15
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation